AVMs are snarled tangles of blood vessels that sometimes form in your body. They may affect up to 6 million Americans, but most don’t experience any negative effects. Samantha Dabney survived her AVM-caused stroke by focusing on her daughter.
News & Events (Page 5)
Get the latest health news from UVA hospital. Learn about current events, clinical trials, medical research taking place here in Charlottesville.
It was a busy holiday season at the Health System. Take a look back at some of the ways we were able to celebrate with our patients, team members and the community.
A new research discovery from the School of Medicine about the effects of aging in our cells could help doctors cure diabetes, liver disease or possibly even reverse aging.
Dedicated to women, the Summer Vim & Vigor, our family health magazine, has you covered for warmer, healthier days ahead. Here’s a glimpse of what you’ll find inside.
We haven’t yet found an Alzheimer’s disease cure. But our recent research announcements are good progress toward treating the sixth leading cause of death in the U.S.
Your high standards could be harming your health. The spring 2018 issue of Vim & Vigor, our family health magazine, takes a closer look at this problem.
Look back on our 2017 stories: A video about an 11-year-old's rare disease, plus LGBTQ health, talking to kids about violence, ketogenic diet and apple cider vinegar's health benefits.
Learn how a positive attitude and simple changes to your daily routine can improve your health. Plus, inspiring patient stories and more health tips in this issue of our family health magazine.
The Department of Radiology and Medical Imaging has launched a new resource specifically for patients: InsideView is our unconventional blog, intended to bring patients behind the scenes and help answer their radiology questions before they arise.
While pediatric oncologist Daniel “Trey” Lee was working at the NIH, he tested a form of gene therapy as a possible way to save children with leukemia. Now at UVA, Lee just gave the first dose of an experimental immunotherapy to a 14-year-old with acute lymphoblastic leukemia.
Subscribe for Updates
Get stories & health tips every week